Hospira Vancomycin 10g Vials Recall: Hair in Product May Cause Infection
Hospira recalls 10g Vancomycin Hydrochloride vials due to hair found inside one vial that could contact reconstituted drug. Affected pharmacy bulk packages sold in the US.
Lower-risk recall
Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.
Contact the company
What happened, in plain English
Hospira is recalling 10-gram Vancomycin Hydrochloride vials that may contain hair inside the vial. This hair could contact the reconstituted drug during use, potentially causing infection. The recall affects pharmacy bulk packages sold in the US. Read more at govinfonow.com/recall/42071-hospira-vancomycin-10g-vials-recall-hair-in-product-may-cause.
Source Summary by GovInfoNow · govinfonow.com/recall/42071-hospira-vancomycin-10g-vials-recall-hair-in-product-may-cause · Updated October 8, 2026 · FDA enforcement record: FDA #D-0638-2017
Cite this page
“Hospira Vancomycin 10g Vials Recall: Hair in Product May Cause Infection.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42071-hospira-vancomycin-10g-vials-recall-hair-in-product-may-cause. Based on FDA recall #D-0638-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0638-2017%22&limit=1).
Why it’s dangerous
A single vial contained hair that could contact the reconstituted drug product. This hair might introduce contaminants during injection, potentially causing infection in patients. The hazard is limited to one vial per batch.
Who’s affected
Pharmacists and healthcare facilities using the recalled pharmacy bulk packages for intravenous use. Patients receiving treatment with this specific vial type are at risk if the vial is used without proper inspection.
How to tell if you have this one
Check for vials with NDC 0409-6510-01, Lot # 591053A, and expiration date 11/1/2017. The vials are 100 mL glass containers labeled for pharmacy bulk use, not direct patient infusion.
- Brand
Hospira- Category
Drug
What to do — step by step
Check Vial Contents
Inspect the vial for hair or other particles before use. If hair is present, do not use the vial.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0638-2017 (January 24, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0638-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.